Prosecution Insights
Last updated: November 20, 2026

Amelia Nicole Dickens, USPTO Patent Examiner

Listed by the USPTO as DICKENS, AMELIA NICOLE

Tech Center 1600 • Art Units: 1644 1645 1671

This examiner grants 48% of resolved cases

Analysis

DICKENS, AMELIA NICOLE is assigned to art unit 1644 within tech center 1600. The profile includes 128 resolved cases, an allowance rate of 47.7%, and a median of 1277 days to allowance. Interviews are associated with a 22.5% lift in the allowance measure.

Listed company matters include Intervet Inc., The Regents of the University of California, and CJ CheilJedang Corporation. Listed firms are Morgan, Lewis & Bockius LLP (WA), SUGHRUE MION, PLLC, and ARENTFOX SCHIFF LLP. Practitioners can use the combination of recorded timing and interview response to structure prosecution plans, while the case volume calls for care in treating the profile as a prediction for any individual application.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

47.7%
Allow Rate
-12.3% vs TC avg
186
Total Applications
+22.5%
Interview Lift
1277
Avg Prosecution Days
Based on 128 resolved cases, 2023–2026

Rejection Statute Breakdown

6.5%
§101 Eligibility
20.6%
§102 Novelty
22.2%
§103 Obviousness
36.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18016432 RECOMBINANT MICROORGANISMS Non-Final OA The Regents of the University of California
18852236 COMPOSITION CONTAINING BACILLUS AMYLOLIQUEFACIENS STRAIN FOR ENHANCING PLANT DISEASE RESISTANCE AND USE THEREOF Non-Final OA CJ CHEILJEDANG CORPORATION
19150973 METHODS FOR PRODUCING HIGH-LEVEL SQUALENE Non-Final OA Massachusetts Institute of Technology
18574816 BIFIDOBACTERIUM LONGUM TRANSITIONAL MICROORGANISMS, COMPOSITIONS AND USES THEREOF Non-Final OA Société des Produits Nestlé S.A.
18690364 METHOD AND COMPOSITION FOR REDUCING OR PREVENTING FIRE BLIGHT DISEASE IN A POME FRUIT TREE Final Rejection The Penn State Research Foundation
18665951 PNEUMOCOCCAL CONJUGATE VACCINES AND METHODS OF USE THEREOF Non-Final OA Merck Sharp & Dohme LLC
18466984 METHOD FOR PRODUCING FOREIGN PROTEIN USING E. COLI Non-Final OA KANEKA CORPORATION
19161632 Use of O-Antigens for Treating Bacterial Infections Non-Final OA Agency for Science, Technology and Research
18292542 VACCINE COMPOSITIONS COMPRISING BRUCELLA STRAINS AND METHODS THEREOF Final Rejection THE TEXAS A&M UNIVERSITY SYSTEM
18286005 ENCAPSULATED MICROBIAL COMPOSITIONS AND METHODS OF MAKING THE SAME Final Rejection Monsanto Technology LLC
17788224 PROCESS TO IDENTIFY CONSORTIA OF PROBIOTIC STRAINS SUITABLE FOR GLUTEN DEGRADATION Final Rejection Evonik Operations GmbH
17335578 METHODS FOR ASSESSING EFFICACY OF A DRUG IN VIVO BY MONITORING ADME PROTEINS IN EXTRACELLULAR VESICLES Final Rejection Purdue Research Foundation
18167664 Microbially Induced Inflammation Produces Changes in Distinct Healthy Tissues in Human Oral Cavity Final Rejection Colgate-Palmolive Company
18261226 COMPOSITION FOR DECOMPOSITION OF TRYPSIN OR TMPRSS2 Non-Final OA Keio University
18467134 COMPLEX OR SALT THEREOF, AND METHOD FOR PRODUCING THE SAME Non-Final OA Ajinomoto Co., Inc.
17775425 A NOVEL VACCINE AGAINST HAEMOPHILUS PARASUIS Non-Final OA Intervet Inc.
17775428 NOVEL VACCINE AGAINST HAEMOPHILUS PARASUIS Non-Final OA Intervet Inc.
18824806 METHODS FOR DETERMINING ANTIBIOTIC SENSITIVITY Non-Final OA RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL
18287081 GROWTH PROMOTER FOR LACTIC ACID COCCI Final Rejection KIRIN HOLDINGS KABUSHIKI KAISHA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Amelia Nicole Dickens's allowance rate?

47.7% of resolved applications examined by Amelia Nicole Dickens were allowed (128 resolved cases), compared with 35.8% across Art Unit 1644 over the last five years.

Does an interview help with examiner Amelia Nicole Dickens?

This examiner's interview lift is +22.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Amelia Nicole Dickens take to allow a patent?

Applications allowed by Amelia Nicole Dickens took 1,277 days on average from filing to allowance.

Which art unit does examiner Amelia Nicole Dickens work in?

Amelia Nicole Dickens examines applications in Art Unit 1644 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month